Devin Gattey1, Angela Y Zhu, Anna Stagner, Mark A Terry, Albert S Jun. 1. *Casey Eye Institute, Oregon Health and Science University, Portland, OR; †Case Western Reserve University School of Medicine, Cleveland, OH; ‡Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE; §Devers Eye Institute, Portland, OR; and ¶Wilmer Eye Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
Abstract
PURPOSE: The aim was to report 4 cases of Fuchs endothelial corneal dystrophy (FECD) in patients with an established diagnosis of myotonic dystrophy (DM) and suggest a mechanism for their association based on the known molecular genetics and potential pathophysiological parallels of DM and FECD. METHODS: We reviewed all available medical records and pathology slides for the 4 reported cases from the Department of Ophthalmology at Oregon Health and Science University's Casey Eye Institute and Devers Eye Institute at the Legacy Good Samaritan Medical Center in Portland, OR. RESULTS: Four patients were found to have DM and bilateral corneal guttae, consistent with the diagnosis of FECD. All the identified patients were female and were aged between 34 and 63, and 2 patients were related (mother and daughter). The corneal specimens from 2 of the 4 patients who had undergone a corneal transplant were pathologically confirmed to be consistent with the diagnosis of FECD. CONCLUSIONS: To our knowledge, FECD has not been previously reported in association with DM. Because both diseases are somewhat prevalent in the United States, it is possible that their coexistence is merely a coincidence in these patients. However, recent studies into the pathogenesis of each disease have shown more parallels between FECD and DM, suggesting the possibility of a noncoincidental association. Potential mutual pathogenic mechanisms may involve altered protein expression causing the deregulation of ion homeostasis, an unstable intronic trinucleotide repeat expansion, or activation of the unfolded protein response and oxidative stress pathways.
PURPOSE: The aim was to report 4 cases of Fuchs endothelial corneal dystrophy (FECD) in patients with an established diagnosis of myotonic dystrophy (DM) and suggest a mechanism for their association based on the known molecular genetics and potential pathophysiological parallels of DM and FECD. METHODS: We reviewed all available medical records and pathology slides for the 4 reported cases from the Department of Ophthalmology at Oregon Health and Science University's Casey Eye Institute and Devers Eye Institute at the Legacy Good Samaritan Medical Center in Portland, OR. RESULTS: Four patients were found to have DM and bilateral corneal guttae, consistent with the diagnosis of FECD. All the identified patients were female and were aged between 34 and 63, and 2 patients were related (mother and daughter). The corneal specimens from 2 of the 4 patients who had undergone a corneal transplant were pathologically confirmed to be consistent with the diagnosis of FECD. CONCLUSIONS: To our knowledge, FECD has not been previously reported in association with DM. Because both diseases are somewhat prevalent in the United States, it is possible that their coexistence is merely a coincidence in these patients. However, recent studies into the pathogenesis of each disease have shown more parallels between FECD and DM, suggesting the possibility of a noncoincidental association. Potential mutual pathogenic mechanisms may involve altered protein expression causing the deregulation of ion homeostasis, an unstable intronic trinucleotide repeat expansion, or activation of the unfolded protein response and oxidative stress pathways.
Authors: Christoph Engler; Clare Kelliher; Arielle R Spitze; Caroline L Speck; Charles G Eberhart; Albert S Jun Journal: Am J Ophthalmol Date: 2010-02 Impact factor: 5.258
Authors: Jiaxin Hu; Xiulong Shen; Frank Rigo; Thahza P Prakash; V Vinod Mootha; David R Corey Journal: Nucleic Acid Ther Date: 2019-01-24 Impact factor: 5.486
Authors: Viet Q Chau; Jiaxin Hu; Xin Gong; John D Hulleman; Rafael L Ufret-Vincenty; Frank Rigo; Thahza P Prakash; David R Corey; V Vinod Mootha Journal: Nucleic Acid Ther Date: 2020-03-23 Impact factor: 5.486
Authors: Eric D Wieben; Ross A Aleff; Xiaojia Tang; Malinda L Butz; Krishna R Kalari; Edward W Highsmith; Jin Jen; George Vasmatzis; Sanjay V Patel; Leo J Maguire; Keith H Baratz; Michael P Fautsch Journal: Invest Ophthalmol Vis Sci Date: 2017-01-01 Impact factor: 4.799
Authors: Nelson S Winkler; Margherita Milone; Jennifer M Martinez-Thompson; Harish Raja; Ross A Aleff; Sanjay V Patel; Michael P Fautsch; Eric D Wieben; Keith H Baratz Journal: Invest Ophthalmol Vis Sci Date: 2018-06-01 Impact factor: 4.799
Authors: Yongjun Chu; Jiaxin Hu; Hanquan Liang; Mohammed Kanchwala; Chao Xing; Walter Beebe; C Bradley Bowman; Xin Gong; David R Corey; V Vinod Mootha Journal: Nucleic Acids Res Date: 2020-07-09 Impact factor: 16.971
Authors: Eric D Wieben; Ross A Aleff; Xiaojia Tang; Krishna R Kalari; Leo J Maguire; Sanjay V Patel; Keith H Baratz; Michael P Fautsch Journal: PLoS One Date: 2018-07-02 Impact factor: 3.240